Suppr超能文献

印度血液学与输血学会(ISHBT)关于COVID-19大流行期间血液学实践的共识文件。

Indian Society of Hematology and Blood Transfusion (ISHBT) Consensus Document on Hematological Practice During COVID-19 Pandemic.

作者信息

Kar Rakhee, Dolai Tuphan Kanti, Shekhawat Prakash Singh, Malhotra Pankaj, Singh Avinash, Naithani Rahul, Mandal Prakas Kumar, Ganesan Prasanth, Manivannan Prabhu, Basu Debdatta, Srivastava Alok, Das Reena, Bhattacharya Maitreyee, Mahapatra Manoranjan, Dhawan Rishi, Jain Arihant, Bhandary Chandni, Pati Hara Prasad, Chatterjee Tathagata, Tilak Vijai, Chandra Sarmila, Shetty Shrimati Dharampal, Jena Rabindra Kumar

机构信息

Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Haematology Department, NRS Medical College and Hospital, Kolkata, India.

出版信息

Indian J Hematol Blood Transfus. 2021 Jan;37(1):1-9. doi: 10.1007/s12288-021-01405-0. Epub 2021 Feb 16.

Abstract

The SARS-CoV-2 (COVID-19) pandemic is a worldwide public health emergency with widespread impact on health care delivery. Unforeseen challenges have been noted during administration of usual haematology care in these unusual COVID-19 times. Medical services have been overstretched and frontline health workers have borne the brunt of COVID-19 pandemic. Movement restrictions during lockdown prevented large sections of population from accessing health care, blood banks from holding blood drives, and disrupted delivery of diagnostic hematology services. The disruption in hematology care due to COVID-19 pandemic in India has been disproportionately higher compared to other subspecialities as hematology practice in India remains restricted to major cities. In this review we chronicle the challenges encountered in caring for hematology patients during the COVID-19 pandemic in India and put forth recommendations for minimizing their impact on provision of hematology care with special emphasis on hematology practice in lower and middle income countries (LMICs).

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新冠病毒)大流行是一场全球公共卫生突发事件,对医疗服务产生了广泛影响。在这些不同寻常的新冠疫情时期,常规血液学护理的实施过程中出现了一些意想不到的挑战。医疗服务不堪重负,一线医护人员首当其冲受到新冠疫情的冲击。封锁期间的行动限制使大部分人口无法获得医疗服务,血库无法举办献血活动,诊断性血液学服务的提供也受到干扰。与其他亚专业相比,印度因新冠疫情导致的血液学护理中断情况尤为严重,因为印度的血液学实践仍局限于大城市。在本综述中,我们记录了印度在新冠疫情期间护理血液学患者时遇到的挑战,并提出建议,以尽量减少其对血液学护理提供的影响,特别强调低收入和中等收入国家(LMICs)的血液学实践。

相似文献

1
Indian Society of Hematology and Blood Transfusion (ISHBT) Consensus Document on Hematological Practice During COVID-19 Pandemic.
Indian J Hematol Blood Transfus. 2021 Jan;37(1):1-9. doi: 10.1007/s12288-021-01405-0. Epub 2021 Feb 16.
2
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
Med J Aust. 2020 Jun;212(10):481-489. doi: 10.5694/mja2.50607. Epub 2020 May 13.
3
Transfusion practices during the COVID-19 pandemic: An experience from a hematology daycare in India.
Transfus Apher Sci. 2021 Apr;60(2):103025. doi: 10.1016/j.transci.2020.103025. Epub 2020 Nov 26.
4
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.
Leuk Lymphoma. 2022 Mar;63(3):538-550. doi: 10.1080/10428194.2021.1992619. Epub 2021 Oct 20.

引用本文的文献

1
Role of microRNA-486-5p as Biomarker Response in Cell Line K562 of Chronic Myeloid Leukemia.
Asian Pac J Cancer Prev. 2025 Apr 1;26(4):1181-1187. doi: 10.31557/APJCP.2025.26.4.1181.

本文引用的文献

1
HSCT Guidelines for Transplant Practices During the COVID-19 Pandemic in India ISBMT DOCUMENT Version1.0.
Blood Cell Ther. 2020 May 28;3(3):59-70. doi: 10.31547/bct-2020-003. eCollection 2020 Aug 25.
2
Lived Experiences of COVID-19 Intensive Care Unit Survivors.
Indian J Psychol Med. 2020 Jul 7;42(4):387-390. doi: 10.1177/0253717620933414. eCollection 2020 Jul.
3
How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?
Indian J Hematol Blood Transfus. 2020 Oct;36(4):605-615. doi: 10.1007/s12288-020-01300-0. Epub 2020 Jun 6.
4
Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome.
Blood Adv. 2020 Aug 25;4(16):3840-3849. doi: 10.1182/bloodadvances.2020002511.
6
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current Therapies.
Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):e734-e751. doi: 10.1016/j.clml.2020.05.027. Epub 2020 Jun 7.
8
COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature.
Crit Rev Oncol Hematol. 2020 Aug;152:102991. doi: 10.1016/j.critrevonc.2020.102991. Epub 2020 May 21.
9
The role of telemedicine in the delivery of health care in the COVID-19 pandemic.
Haemophilia. 2020 Sep;26(5):e230-e231. doi: 10.1111/hae.14044. Epub 2020 Jul 22.
10
Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations.
Am J Hematol. 2020 Aug;95(8):E208-E210. doi: 10.1002/ajh.25857. Epub 2020 May 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验